Inmune Bio, Inc.
Company Information
Industry Biological Products, (No Diagnostic Substances)
SIC Code 2836
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation NV
Business Address 225 NE MIZNER BLVD, SUITE 640, BOCA RATON, FL, 33432
Mailing Address 225 NE MIZNER BLVD, SUITE 640, BOCA RATON, FL, 33432
Phone 8589643720
Fiscal Year End 1231
EIN 475205835
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 10-K Annual financial report | March 30, 2026 | View on SEC |
| 8-K Current report of material events | February 27, 2026 | View on SEC |
| 8-K Current report of material events | February 23, 2026 | View on SEC |
| 8-K Current report of material events | February 19, 2026 | View on SEC |
| 8-K Current report of material events | February 13, 2026 | View on SEC |
| 8-K Current report of material events | January 27, 2026 | View on SEC |
| 8-K Current report of material events | December 23, 2025 | View on SEC |
| 424B5 Prospectus supplement | December 19, 2025 | View on SEC |
| 8-K Current report of material events | December 19, 2025 | View on SEC |
| 8-K Current report of material events | December 10, 2025 | View on SEC |
Annual Reports
10-K March 30, 2026
- Lead drug CORDStrom showed safety and efficacy in Phase 2 trials for RDEB.
- Targeting regulatory filings for CORDStrom in the UK, EU, and U.S. by late 2026.
Related Companies
Companies in the same industry (SIC: 2836)
Kodiak Sciences Inc.
KOD Biological Products, (No Diagnostic Substances)
BioAtla, Inc.
BCAB Biological Products, (No Diagnostic Substances)
BRAINSTORM CELL THERAPEUTICS INC.
BCLI Biological Products, (No Diagnostic Substances)
Alvotech
ALVO Biological Products, (No Diagnostic Substances)
Liminatus Pharma, Inc.
LIMN Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.